Skip to content
Subscribe
  • Home
  • News
  • AI
  • Cardiac
  • Robotics
  • FDA
  • M&A
  • Insight Hub
  • Home
  • News
  • AI
  • Cardiac
  • Robotics
  • FDA
  • M&A
  • Insight Hub

iRhythm Stock Jumps on Strong Q4 Results and FDA Progress

Sales beat expectations; regulatory remediation on track iRhythm (Nasdaq: IRTC) shares surged 8% following better-than-expected Q4 results and progress in addressing FDA compliance concerns. Key

Read More »

FDA Labels Boston Scientific Pacemaker Recall as Serious

Battery issue may cause device failure, injury, or death The FDA has classified the Boston Scientific Accolade pacemaker recall as a Class I recall, the

Read More »

Philips Issues Safety Notice for IntelliSpace Cardiovascular System

Software issue may impact study data management Philips has issued an urgent field safety notice for its IntelliSpace Cardiovascular (ISCV) 7.0 system in Europe due

Read More »

Medtronic Unveils ModuLeX Spinal System for Deformity Surgery

New system integrates AI-driven precision for spinal procedures Medtronic has officially launched the CD Horizon ModuLeX spinal system, designed to enhance spinal deformity procedures. The

Read More »

Philips, Mass General Brigham Partner on AI-Powered Patient Care

Collaboration to develop real-time data insights for clinicians Philips has announced a strategic collaboration with Mass General Brigham (MGB) to enhance AI-driven healthcare infrastructure. The

Read More »

Medtronic Wins FDA Approval for Adaptive DBS in Parkinson’s

BrainSense technology offers real-time, personalized therapy Medtronic has received FDA approval for its BrainSense adaptive deep brain stimulation (aDBS) platform, marking a major milestone in

Read More »
Linkedin

Get the MEDWIRE.AI Newsletter

Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.

© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.

  • Home
  • News
  • AI
  • Cardiac
  • Robotics
  • FDA
  • M&A
  • Insight Hub
  • Home
  • News
  • AI
  • Cardiac
  • Robotics
  • FDA
  • M&A
  • Insight Hub
  • Home
  • News
  • AI
  • Cardiac
  • Robotics
  • FDA
  • M&A
  • Insight Hub
  • Home
  • News
  • AI
  • Cardiac
  • Robotics
  • FDA
  • M&A
  • Insight Hub
Subscribe